AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 127.04 No Change ▼ 0.00 (0%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.51 No Change ▼ 0.00 (0%)
DCL 8.55 No Change ▼ 0.00 (0%)
DFML 41.44 No Change ▼ 0.00 (0%)
DGKC 86.85 No Change ▼ 0.00 (0%)
FCCL 32.28 No Change ▼ 0.00 (0%)
FFBL 64.80 No Change ▼ 0.00 (0%)
FFL 10.25 No Change ▼ 0.00 (0%)
HUBC 109.57 No Change ▼ 0.00 (0%)
HUMNL 14.68 No Change ▼ 0.00 (0%)
KEL 5.05 No Change ▼ 0.00 (0%)
KOSM 7.46 No Change ▼ 0.00 (0%)
MLCF 41.38 No Change ▼ 0.00 (0%)
NBP 60.41 No Change ▼ 0.00 (0%)
OGDC 190.10 No Change ▼ 0.00 (0%)
PAEL 27.83 No Change ▼ 0.00 (0%)
PIBTL 7.83 No Change ▼ 0.00 (0%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.88 No Change ▼ 0.00 (0%)
PTC 16.07 No Change ▼ 0.00 (0%)
SEARL 86.00 No Change ▼ 0.00 (0%)
TELE 7.71 No Change ▼ 0.00 (0%)
TOMCL 35.41 No Change ▼ 0.00 (0%)
TPLP 8.12 No Change ▼ 0.00 (0%)
TREET 16.41 No Change ▼ 0.00 (0%)
TRG 53.29 No Change ▼ 0.00 (0%)
UNITY 26.16 No Change ▼ 0.00 (0%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 10,010 Increased By 126.5 (1.28%)
BR30 31,023 Increased By 422.5 (1.38%)
KSE100 94,192 Increased By 836.5 (0.9%)
KSE30 29,201 Increased By 270.2 (0.93%)

Drug Regulatory Agency of Pakistan (Cabinet Division), in exercise of the powers conferred by section 12 of the Drugs Act, 1976 (XXXI of 1976), the Federal Government, through a notification, has allowed addition of up to Rs 4 and Rs 10 per bottle of 60ml, 120ml and 450ml respectively in their respective Maximum Retail Prices (MRPs) of liquid cough preparations fixed by the federal government.
Subject to the fulfilment following conditions namely:
(i) valid drug manufacturing license/ drug sale license and drug registration.
(ii) the manufacturers and importers of drugs shall furnish the MRPs of drugs with evidence to the Pricing Section before implementation and stickers are not allowed.
(iii) print the retail price on the label in the manner prescribed by the Drugs (Labelling and Packing) Rules; and (iv) raw material used for drugs manufacturing shall be purchased from established source per official pharmacopoeia under section 3 of Drugs Act 1976.-PR

Copyright Business Recorder, 2012

Comments

Comments are closed.